Joined September 2021
We're excited to share #ProtaGene's Heidelberg site is now accredited for GLP-compliant analytical services for Lentriviral Integration Site Analysis (ISA) & VCN assays.聽馃敩 This accreditation enhances our ability to support both GLP & non-GLP projects with trusted expertise.聽馃挕
98
We're thrilled to introduce聽Mike Stump as our new President, US!聽馃専 Mike's leadership will drive us to new heights and continue to foster a culture of innovation and collaboration at #ProtaGene. We're excited to embark on this new journey together.聽馃挕 #Leadership #biopharma
45
From research through commercial product release and testing, we provide the most advanced, integrated, and complete analytical capabilities for our clients. Discover our advanced analytical capabilities in our Fact Sheet below. 猬囷笍 #biopharma #celltherapy #genetherapy
1
60
Our biosimilarity programs evaluate structure and physiochemical properties, biological safety, and more. 鉁旓笍 Learn how we design comparability studies and analysis settings precisely tailored to your needs here: bit.ly/40V9hiS #biopharma #biologics #ProtaGene
42
Since proteins are sensitive to environmental factors, changes in biopharmaceutical stability can alter protein folding & structure. Discover how ProtaGene can help with an early assessment of #biopharma stability for your development programs. 猬囷笍 #stabilitytesting #biologics
44
#DYK meticulous characterization from candidate selection to QC testing is vital for biopharmaceutical developments? 馃挕 Learn how ProtaGene thoroughly generates all data 馃搳 needed for your product's characterization: bit.ly/3SL5rmK #Biologics #Biopharma
22
What are the benefits of working with #ProtaGene when it comes to host protein cell analysis? 馃敩 Check out the details in our infographic here. 猬囷笍 #biopharma #biotech
29
In #biopharma, polysorbates are crucial for keeping protein-based drugs stable. ProtaGene's innovative analytical methods聽馃挕聽ensure thorough polysorbate characterization and quality control, safeguarding drug efficacy & safety. Find out more. 鉃★笍 bit.ly/4dHA6e4
59
Meticulous characterization from candidate selection to QC testing is vital for biopharmaceutical developments. Discover how ProtaGene thoroughly generates all data 馃搳 needed for your product's characterization: bit.ly/3SL5rmK #Biologics #Biopharma
33
From Nobel Prize winners to scientists at the very cutting-edge of the field, we're excited to join over 100 world-leading experts at #ESGCT2024 this week! 馃 Our team can't wait to meet you in booth 17.聽馃搷 @ESGCT #celltherapy #genetherapy
48
Why do leading global pharmaceutical organizations trust #ProtaGene to accelerate and de-risk their therapeutic development programs? 馃敩 鉁旓笍 Analytical Excellence 鉁旓笍 Deep Expertise 鉁旓笍 Quality Systems Find out more: bit.ly/3OAeSDK #biopharma #celltherapy
37
Vector shedding represents an important safety risk in the clinical administration of viral vector-based gene therapies. Our state-of-the-art instrumentation & automation supports your vector shedding studies.馃敩 Learn more in our Bioanalysis Spotlight.馃憞#biopharma
46
Polysorbates are crucial for keeping protein-based drugs stable. Regulatory聽bodies require monitoring of these compounds due to potential聽impurities. Our innovative analytical methods聽ensure聽thorough polysorbate characterization & quality control. 鉃★笍 bit.ly/4dHA6e4
27
From Nobel Prize winners to scientists at the very cutting-edge of the field, we're excited to join over 100 world-leading experts at #ESGCT2024.聽馃 Our team can't wait to meet you in booth 17. 馃搷 @ESGCT #celltherapy #genetherapy
36
We're thrilled to be a part of @alliancerm's #CGMesa24!聽馃敩 Join the #ProtaGene team next week to connect, collaborate, and explore the latest innovations in #biotech and #pharma.聽馃挕 See you there!
1
44
Since proteins are sensitive to environmental factors, changes in biopharmaceutical stability can alter protein folding and structure. Learn how ProtaGene can help with an early assessment of #biopharma stability for your development programs. 馃敩 bit.ly/3XFwJP5
50
Polysorbates are crucial for keeping protein-based drugs stable. Regulatory聽bodies require monitoring of these compounds due to potential聽impurities. Our innovative analytical methods聽馃摲聽ensure聽thorough polysorbate characterization & quality control: bit.ly/4dHA6e4
30
Did you know we offer a range of genomic capabilities 馃摑 to support your analytical development? Find out more. 鉃★笍 bit.ly/450ZgAG #biopharma #celltherapy #genetherapy
37
From research through commercial product release and testing, we provide the most advanced, integrated, and complete analytical capabilities for our clients. 馃敩 Discover our advanced analytical capabilities in our Fact Sheet here. 猬囷笍 #biopharma #biologics
36
Cell & gene therapies have the potential to provide long-term therapeutic efficacy, but their development is both risky and cost-intensive. 鈿狅笍 Check out 6锔忊儯 analytical strategies to consider before submitting your cell and gene therapy application. #biopharma #celltherapy
31